Early stage IT and Healthcare Investing

Dynavax Technologies

portfoliocompanies

company snapshot

Dynavax Technologies

Dynavax Technologies discovers and develops products to prevent and treat infectious and inflammatory diseases. Its clinical-stage product candidates include HEPLISAV ™ Hepatitis B Vaccine, Universal Flu Vaccine , TLR Inhibitor for Lupus and Hepatitis B Therapy. The company partners with AstraZeneca, GlaxoSmithKline and other pharmaceutical companies.

website
www.dynavax.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share